Jean‐Sébastien Brunet

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

Steven A. Narod, Harvey A. Risch, Roxana Moslehi et al. · New England Journal of Medicine · 1998 · 619 citations · Full text

Medicine, Gynecology, Oncology +13

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

Emad A. Rakha, Somaia Elsheikh, Mohammed A. Aleskandarany et al. · Clinical Cancer Research · 2009 · 485 citations

Medicine, Oncology, Pathology +11

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

Elizabeth Warner, William D. Foulkes, Pamela J. Goodwin et al. · JNCI Journal of the National Cancer Institute · 1999 · 394 citations · Full text

Life Sciences, Genetics, Oncology +16

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Marc Tischkowitz, Jean‐Sébastien Brunet, Louis R. Bégin et al. · BMC Cancer · 2007 · 368 citations · Full text

Medicine, Oncology, Pathology +17

The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of <b> <i>BRCA1</i> </b>-Related Breast Cancer

William D. Foulkes, Jean‐Sébastien Brunet, Ingunn M. Stefansson et al. · Cancer Research · 2004 · 364 citations

Medicine, Genetics, Oncology +14